Blood online
Home About Blood Authors Subscriptions Permission Advertising Public Access contact us
 

 
Advanced
Current Issue
First Edition
Future Articles
Archives
Submit to Blood
Search
American Society of Hematology
Meeting Abstracts
Email Alerts
Blood, 15 September 2005, Vol. 106, No. 6, pp. 1965-1974.
Prepublished online as a Blood First Edition Paper on June 9, 2005; DOI 10.1182/blood-2004-10-3975.


This Article
Right arrow Full Text (PDF)
Right arrow Supplemental Tables
Right arrow All Versions of this Article:
2004-10-3975v1
106/6/1965    most recent
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Right arrow Rights and Permissions
Citing Articles
Right arrow Citing Articles via CrossRef
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Jacquelin, B.
Right arrow Articles by Tronik-Le Roux, D.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Jacquelin, B.
Right arrow Articles by Tronik-Le Roux, D.
Social Bookmarking
 Add to CiteULike   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati  
What's this?

arrow to previous article Previous Article  |  Next Article next article arrow

Submitted October 15, 2004
Accepted May 16, 2005

A novel pathway for megakaryocyte production following in vivo conditional eradication of integrin {alpha}IIb expressing cells

Beatrice Jacquelin, Thierry Kortulewski, Pierre Vaigot, Alexandre Pawlik, Gaetan Gruel, Olivier Alibert, Pascal Soularue, Christophe Joubert, Xavier Gidrol, and Diana Tronik-Le Roux*

Laboratoire de Genomique et Radiobiologie de l'Hematopoiese, Service de Genomique Fonctionnelle, Evry, France
Laboratoire d'Exploration Fonctionnelle des Genomes, Service de Genomique Fonctionnelle, Evry, France
Laboratoire de Cancerologie Experimentale, Commissariat a l'Energie Atomique, Fontenay-aux-Roses, France

* Corresponding author; email: diana.le-roux{at}cea.fr.

Our knowledge of the molecular mechanisms that regulate hematopoiesis in both, physiological and pathological conditions is limited. Using a molecular approach based on cDNA microarrays, we demonstrate the emergence of an alternative pathway for mature bone marrow cells recovery following the programmed and reversible eradication of CD41+ cells in transgenic mice expressing a conditional toxigene targeted by the platelet {alpha}IIb promoter. The expression profile of the newly produced CD41+ cells showed high levels of transcripts encoding Ezh2, TdT, Rag2, and various immunoglobulin heavy chains. In this context, we identified and characterized a novel population of Lin-Sca-1hic-Kit- cells, with a lymphoid-like expression pattern, potentially involved in the reconstitution process. Our study revealed novel transcriptional cross-talk between myeloid and lymphoid lineages and identified gene expression modifications that occur in vivo under these particular stress conditions, opening important prospects for therapeutic applications.


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati    What's this?




 click for free articles
home about blood authors subscriptions permissions advertising public access contact us
  Copyright © 2005 by American Society of Hematology         Online ISSN: 1528-0020